Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations

被引：1
|
作者：
Hoste, G. [1 ]
D'Hoore, P. [1 ]
Legius, E. [1 ]
Van Buggenhout, G. [1 ]
Floris, G. [1 ]
Wildiers, H. [1 ]
Han, S. N. [1 ]
Van Nieuwenhuysen, E. [1 ]
Berteloot, P. [1 ]
Smeets, A. [1 ]
Nevelsteen, I. [1 ]
Weltens, C. [1 ]
Janssen, H. [1 ]
Van Limbergen, E. [1 ]
Neven, P. [1 ]
Punie, K. [1 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-09-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-05
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants A Comparative Modeling Analysis
    Lowry, Kathryn P.
    Geuzinge, H. Amarens
    Stout, Natasha K.
    Alagoz, Oguzhan
    Hampton, John
    Kerlikowske, Karla
    de Koning, Harry J.
    Miglioretti, Diana L.
    van Ravesteyn, Nicolien T.
    Schechter, Clyde
    Sprague, Brian L.
    Tosteson, Anna N. A.
    Trentham-Dietz, Amy
    Weaver, Donald
    Yaffe, Martin J.
    Yeh, Jennifer M.
    Couch, Fergus J.
    Hu, Chunling
    Kraft, Peter
    Polley, Eric C.
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    Robson, Mark E.
    JAMA ONCOLOGY, 2022, 8 (04) : 587 - 596
  • [32] Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.
    Lowry, Kathryn P.
    Geuzinge, H. Amarens
    Stout, Natasha K.
    Alagoz, Oguzhan
    Hampton, John M.
    Kerlikowske, Karla
    Miglioretti, Diana L.
    Schecter, Clyde
    Sprague, Brian L.
    Trentham-Dietz, Amy
    Tosteson, Anna N. A.
    Van Ravesteyn, Nicolien
    Yaffe, Martin
    Yeh, Jennifer
    Couch, Fergus
    Kraft, Peter
    Polley, Eric
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    Robson, Mark E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
    Walsh, T
    Casadei, S
    Coats, KH
    Swisher, E
    Stray, SM
    Higgins, J
    Roach, KC
    Mandell, J
    Lee, MK
    Ciernikova, S
    Foretova, L
    Soucek, P
    King, MC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (12): : 1379 - 1388
  • [34] Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
    Woodward, Emma R.
    van Veen, Elke M.
    Forde, Claire
    Harkness, Elaine F.
    Byers, Helen J.
    Ellingford, Jamie M.
    Burghel, George J.
    Schlech, Helene
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    Gareth Evans, D.
    GENETICS IN MEDICINE, 2021, 23 (10) : 1969 - 1976
  • [35] Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
    Christos Petridis
    Iteeka Arora
    Vandna Shah
    Anargyros Megalios
    Charlotte Moss
    Anca Mera
    Angela Clifford
    Cheryl Gillett
    Sarah E. Pinder
    Ian Tomlinson
    Rebecca Roylance
    Michael A. Simpson
    Elinor J. Sawyer
    Breast Cancer Research, 21
  • [36] Clinical Outcomes in Breast Cancer Patients with Underlying Germline PALB2 Mutations Treated with Radiation
    Shalaby, A.
    Jan, I.
    Ohri, N.
    Abou Yehia, Z.
    Toppmeyer, D.
    Haffty, B. G., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E331 - E332
  • [37] Phase 2 Trial Testing The PARP Inhibitor Niraparib In Patients With Advanced Pancreatic Cancer with Pathogenic Variants In BRCA 1, BRCA2, PALB2, ATM and CHEK2
    Huffman, Brandon M.
    Crowdis, Jett
    Yurgelun, Matthew B.
    Horick, Nora
    Li, Yvonne
    Huy Nguyen
    Parmar, Kalindi
    Kochupurakkal, Bose S.
    Enzinger, Andrea
    Giannakis, Marios
    McCleary, Nadine
    Ng, Kimmie
    Patel, Anuj K.
    Perez, Kimberly J.
    Rubinson, Douglas A.
    Schlechter, Benjamin L.
    Singh, Harshabad
    Lam, Helen
    Ramsey, Kaitlyn
    Andrews, Elizabeth
    Culnane, Leigh
    Bullock, Andrea
    Rattani, Ahmed
    Clark, Jeffrey
    Peters, Mary Linton
    Wolpin, Brian M.
    D'Andrea, Alan D.
    Shapiro, Geoffrey I.
    Aguirre, Andrew J.
    Cleary, James M.
    CANCER RESEARCH, 2024, 84 (17)
  • [38] A PALB2 germline mutation associated with hereditary breast cancer in Italy
    Laura Papi
    Anna Laura Putignano
    Caterina Congregati
    Irene Piaceri
    Ines Zanna
    Francesco Sera
    Doralba Morrone
    Maurizio Genuardi
    Domenico Palli
    Familial Cancer, 2010, 9 : 181 - 185
  • [39] TP53 and CHEK2 germline mutations in malignant solid tumors.
    Zhang, Zhiye
    Wu, Yaqing
    Luo, Ningning
    Zhang, Qin
    Han, Tiantian
    Bu, Xuesong
    Shuai, Qin
    Qi, Yingxue
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] A PALB2 germline mutation associated with hereditary breast cancer in Italy
    Papi, Laura
    Putignano, Anna Laura
    Congregati, Caterina
    Piaceri, Irene
    Zanna, Ines
    Sera, Francesco
    Morrone, Doralba
    Genuardi, Maurizio
    Palli, Domenico
    FAMILIAL CANCER, 2010, 9 (02) : 181 - 185
12345